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Abstract 
Background: The clinical interest of using bubble humidification of oxygen remains controversial. This study was 
designed to further explore whether delivering dry oxygen instead of bubble-moistened oxygen had an impact on 
discomfort of ICU patients.
Methods: This randomized multicenter non-inferiority open trial included patients admitted in intensive care unit 
and receiving oxygen. Any patient receiving non-humidified oxygen (between 0 and 15 L/min) for less than 2 h could 
participate in the study. Randomization was stratified based on the flow rate at inclusion (less or more than 4 L/min). 
Discomfort was assessed 6–8 and 24 h after inclusion using a dedicated 15-item scale (quoted from 0 to 150).
Results: Three hundred and fifty-four ICU patients receiving non-humidified oxygen were randomized either in 
the humidified (HO) (n = 172), using bubble humidifiers, or in the non-humidified (NHO) (n = 182) arms. In modified 
intention-to-treat analysis at H6–H8, the 15-item score was 26.6 ± 19.4 and 29.8 ± 23.4 in the HO and NHO groups, 
respectively. The absolute difference between scores in both groups was 3.2 [90% CI 0.0; + 6.5] for a non-inferiority 
margin of 5.3, meaning that the non-inferiority analysis was not conclusive. This was also true for the subgroups of 
patients receiving either less or more than 4 L/min of oxygen. At H24, using NHO was not inferior compared to HO 
in the general population and in the subgroup of patients receiving 4 L/min or less of oxygen. However, for patients 
receiving more than 4 L/min, a post hoc superiority analysis suggested that patients receiving dry oxygen were less 
comfortable.
Conclusions: Oxygen therapy-related discomfort was low. Dry oxygen could not be demonstrated as non-inferior 
compared to bubble-moistened oxygen after 6–8 h of oxygen administration. At 24 h, dry oxygen was non-inferior 
compared to bubble-humidified oxygen for flows below 4 L/min.
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Background
Oxygen administration is commonly recognized as a 
source of discomfort [1], potentially linked to insuffi-
cient moisture of the administered gas [2–4]. One study 
published by Andres et al. [5] demonstrated that bubble 
humidification could slightly improve comfort in patients 
requiring oxygen at flow rates < 4  L/min. The improve-
ment in comfort was, however, too small to be clinically 
relevant. By contrast, Wells et  al. [6] showed that non-
heated reservoirs temperature was too low to obtain sig-
nificant humidity in delivered oxygen. In line, Estey et al. 
[7] and Campbell et al. [2] demonstrated the inability of 
bubble humidification to improve comfort, respectively, 
in patients receiving oxygen at flow rates < 4 and > 5  L/
min. More recently, Chanques et al. [3] reported that one-
third of the patients receiving bubble-humidified oxygen 
at flow rates > 5 L/min complained of moderate-to-severe 
discomfort often due to dry nose and/or throat feeling. 
This also suggests a poor effect of bubble humidification, 
at least for high oxygen flows. Finally, a recent meta-
analysis [8] underlined the absence of benefice of using 
bubble humidifiers on nose and throat dryness sensa-
tion, nose bleeding, chest discomfort and abnormal smell 
perceived by the patients. Prospective data are still miss-
ing to definitely conclude. Despite the lack of evidence, 
the 1984 [9], the 2002 [10] and the 2017 [11] guidelines 
stated that there were no objective evidences that routine 
humidification of oxygen using bubble humidifiers was 
useful for flow rates of 1–4 L/min. No recommendations 
were given for higher flows. Nevertheless, bubble humid-
ifiers are extensively used in daily clinical practice.
Our hypothesis was that delivering dry oxygen to criti-
cally ill patients was not inferior than administering bub-
ble-humidified oxygen in terms of induced discomfort. 
The main aim of the present study was thus to compare 
discomfort associated with dry and bubble-humidified 
oxygen administration.
Methods
Trial design
This study was a randomized (allocation ratio 1:1) mul-
ticenter non-inferiority open trial. It took place from 
March 2011 to August 2014 in nine university and non-
university ICUs in France. The list of the participating 
centers with the number of inclusions is given in Addi-
tional Files (AF) (Table AF-1). This study was approved 
by the leading hospital ethics committee (Comité de 
Protection des Personnes Ouest II) under the reference 
2010-24. It was performed in accordance with the ethi-
cal standards laid down in the 1964 Declaration of Hel-
sinki and its later amendments. According to French 
laws, as studied oxygen administration strategies are 
both considered as standard of care, written informed 
consent was not required. The investigators informed 
patients about the trial orally and with a written docu-
ment. Patients were informed that they could decline to 
participate at any time, and their decision was recorded 
in patient files. The study was registered in ClinicalTrials.
gov (NCT01300845).
Participants
Any patient hospitalized in the ICU receiving non-
humidified oxygen (between 1 and 15  L/min) through 
nasal cannula or face mask for less than 2  h could par-
ticipate in the study. Non-inclusion criteria were 
age < 18  years, pregnancy, protected adults, non-affili-
ated to social security system patients, tracheostomized 
patients, oxygen therapy probably required for less than 
6  h, patients previously ventilated during the hospital 
stay, patients unable to respond to the questionnaire, 
patients who had already participated in the study and 
patients in palliative treatment.
Randomization
Patients were randomized in the bubble-humidified oxy-
gen group (HO) or in the non-humidified oxygen group 
(NHO). As the published recommendations suggest 
that humidification could be particularly useless at flow 
rates ≤ 4  L/min [10], randomization was stratified for 
oxygen flow rates at inclusion lower or higher than this 
threshold.
Interventions
In the HO arm, the  Aquapak® humidifier (Teleflex, Inc., 
Morrisville, NC USA) was used and humidification was 
started as soon as possible after randomization. The 
humidifier was connected to an oxygen flowmeter and 
to the oxygen administration interface (nasal cannulas or 
masks) selected by the clinicians according to their usual 
practice.
Outcomes
The primary endpoint was a 15-item score of discom-
fort assessed between the 6th and 8th hour (H6–H8) 
after inclusion. This score, quoted from 0 to 150 points 
(0 meaning no discomfort and 150 worst discomfort), 
was calculated by adding the points (0–10) given by the 
patient to each of the fifteen following items: oral dryness, 
oral burning sensation, speaking difficulty, thirst, throat 
dryness, sore throat and/or swallowing difficulty, sen-
sation of coolness or warmth in airways, nasal dryness, 
greater need to blow the nose, particular smell sensation, 
eye discomfort, chest discomfort, headache, discom-
fort related to ambient noise and abnormal taste in the 
mouth. Practically to standardize the oxygen-related 
discomfort assessment, a health practitioner asked the 
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patient to quote orally each of the fifteen items of the 
scale one by one by scoring a level of discomfort between 
0 and 10. The fifteen items were selected from data 
reported in the literature at the time of the study begin-
ning [2, 5, 12] and from a previous survey conducted 
in the University Hospital of Angers ICU in 50 patients 
receiving oxygen. The patients were asked to mention 
the main reason of discomfort associated with oxygen 
therapy. To create the 15-item final score, only criteria 
mentioned by two patients or more were selected. The 
15-item discomfort scale and its validation process are 
illustrated in AF (figures AF-1 and AF-2). Both the global 
15-item score values and the percentages of patients with 
a discomfort score of more than 45/150 were recorded. 
Planned secondary endpoints were the global 15-item 
discomfort scores recorded at 24 h (H24) after inclusion, 
the number of patients who were intubated during the 
ICU stay, the number of patients who developed an ear, 
nose or throat (ENT) infection or a corneal lesion dur-
ing the ICU stay, the number of patients who required 
a bronchoscopy, ICU length of stay and ICU mortality. 
When required, the secondary outcomes were censured 
at 28 days. As a post hoc analysis, we also considered the 
percentages of patients with a discomfort score of more 
than 45/150 at H24.
Sample size
As the global 15-item discomfort score was used for the 
first time, the mean expected values and their dispersion 
were not known. Consequently, no formal a priori sample 
size calculation could be performed. On the basis of the 
Campbell study results [2], it was anticipated to record 
a mean 15-item discomfort score of about 45/150 points 
with a relatively low dispersion of the values (standard 
deviation of the mean of less than 20% of the mean value). 
Thereby, a sample size of 350 patients (175 by group) was 
anticipated to be large enough to conclude.
Statistical methods
Only the patients for whom the primary outcome was 
available were included in the analyses. A non-scored 
item of the 15-item comfort score was computed as 0. 
According to the CONSORT recommendation [13], for 
this non-inferiority trial, the primary endpoint results are 
presented as the absolute difference (with 90% confidence 
interval—CI) between the NHO and HO groups. The 
null hypothesis was defined as “mean comfort score value 
in the HO group is more than 20% lower than mean com-
fort score value in the NHO group.” Thus, the non-infe-
riority margin was computed as the mean comfort score 
of the HO group + 20%. Non-inferiority is accepted if this 
margin is not comprised within the CI of the difference 
between HO and NHO comfort scores and if the 90% CI 
includes 0 [13]. The primary endpoint analysis and all the 
comfort score comparisons were performed for non-infe-
riority in per protocol (PP) and modified intention-to-
treat analysis (mITT). mITT means an intention-to-treat 
analysis after exclusion of the patients who did not meet 
inclusion criteria or/and who had a posteriori an exclu-
sion criterion. Normality of continuous variables was 
assessed using the Shapiro–Wilk test. According to the 
usually performed non-inferiority analyses, means and 
standard deviations were used to define non-inferiority 
thresholds, independently from the normality of the data 
distribution. Statistical analyses were performed with 
R, Core Team (2018), version 3.3.3 (Vienna, Austria). A 
p value < 0.05 was considered as statistically significant 
(bilateral tests for all comparisons except for non-infe-
riority analyses). For quantitative variables, statistical 
tests used were the Student’s t test or the nonparametric 
Mann–Whitney test as indicated. Comparisons between 
qualitative variables were made using the Chi-square or 
Fisher’s exact tests as indicated.
Results
Participants
Three hundred and fifty-four patients were randomized 
in the HO (n = 172) or in the NHO (n = 182) arms. Fig-
ure 1 illustrates the flowchart of the study. Patients’ char-
acteristics are mentioned in Table 1.
Outcomes
Figure 2 shows the results of the PP non-inferiority anal-
ysis for the 15-item discomfort score recorded at H6–H8. 
The mean value (± SD) of the 15-item discomfort score at 
H6–H8 was 26.9 ± 20.1 in the HO group (n = 136). The 
corresponding non-inferiority margin (Δ = 20% of 26.9) 
was calculated at +5.4. In the NHO group (n = 141), 
the mean value (± SD) of the 15-item comfort score 
was 29.7 ± 22.9. The absolute difference between HO 
and NHO comfort scores was 2.8 [90% CI − 0.4; +6.0]. 
The non-inferiority margin was within the 90% CI of 
the absolute difference, meaning that the non-inferiority 
analysis was not conclusive [13]. For sensitivity reasons, 
a mITT analysis was also performed [13]. It provided the 
same results as the PP analysis (not shown). Figure AF-3 
illustrates the median (IQR) discomfort scores recorded 
in HO and NHO groups at H6–H8. In the HO group and 
in the NHO group, respectively, 17.6 and 19.0% of the 
patients (p = 0.77) had a 15-item comfort score of more 
than 45/150. Item-by-item results of the 15-item comfort 
score are provided in figure AF-4 of AF.
At H24, in PP analysis, the mean value (± SD) of 
the 15-item discomfort score was 27.9 ± 19.0 in the 
HO group (n = 72). The corresponding non-inferior-
ity margin (Δ = 20% of 27.9) was calculated at +5.6. 
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Fig. 1 Study flowchart. NIV noninvasive ventilation, HHFOT humidified high flow oxygen therapy, ICU intensive care unit
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In the NHO group (n = 86), the mean value (± SD) of 
the 15-item comfort score was 27.4 ± 21.1. The abso-
lute difference between HO and NHO comfort scores 
was −  0.5 [90% CI −  4.3; +3.3], meaning that NHO 
was not inferior to HO [13] (Fig.  3). The mITT analy-
sis gave the same results (not shown). In the HO group 
and in the NHO group, respectively, 18.1 and 17.4% of 
the patients (p = 0.92) had a 15-item comfort score of 
more than 45/150. The median (IQR) comfort scores 
recorded in HO and NHO groups at H24 is displayed in 
Figure AF-3.
The 15-item comfort scores recorded in the subgroups 
of patients who received oxygen, respectively, at flow 
rates ≤ 4  L/min and > 4  L/min were also compared for 
non-inferiority at H6–H8 and H24. Absolute and relative 
differences between NHO group and HO group mean 
scores are given in Table  2 for PP analysis. Relative dif-
ferences are also displayed in Fig.  4. mITT gave the 
Table 1 Patients’ characteristics, reasons for intensive care unit (ICU) admission and past medical history
ENT ear, nose and throat, HO humidified oxygen, NHO non-humidified oxygen
Characteristics Humidified oxygen therapy
(HO group)
(n = 136)
Non-humidified 
oxygen therapy
(NHO group)
(n = 142)
Age (years), median (IQR) 64 (51–77) 63.5 (54.25–74)
Male sex, n (%) 94 (69.1%) 91 (64.1%)
Previous use of oxygen in hospital before ICU admission, n (%) 90 (66.2%) 103 (72.5%)
Previous use of oxygen at home, n (%) 3 (2.2%) 8 (5.7%)
Reasons for ICU admission
Respiratory failure, n (%) 50 (36.8%) 39 (27.5%)
Cardiac failure/lung edema, n (%) 2 (1.5%) 12 (8.5%)
 Sepsis, n (%) 34 (25.0%) 39 (27.5%)
 Renal and metabolic failure, n (%) 15 (11.0%) 15 (10.6%)
 Others, n (%) 35 (25.7%) 37 (26.1%)
Illness potentially influencing evaluation of discomfort score
 ENT cancer, n (%) 5 (3.7%) 5 (3.5%)
 Sjögren’s syndrome, n (%) 0 (0%) 1 (0.7%)
 Past cervical or facial radiotherapy, n (%) 4 (2.9%) 4 (2.8%)
 Past or current tobacco use, n (%) 67 (49.3%) 64 (45.4%)
Fig. 2 Absolute difference (with confidence interval) between the 15-item comfort scores at H6–H8 after randomization between humidified 
oxygen (HO) and non-humidified (NHO) oxygen. The non-inferiority margin was within the 90% CI of the absolute difference, meaning that the 
non-inferiority analysis was not conclusive
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same results (not shown). As at H24 in the subgroup of 
patients receiving oxygen flow > 4 L/min, the confidence 
interval of the difference did not comprise either 0 or the 
non-inferiority margin, a post hoc inferiority analysis 
could be performed [13]. This analysis suggested inferior-
ity of dry oxygen (p = 0.04) at H24 for oxygen flows > 4 L/
min, meaning that discomfort was higher when no bub-
ble humidification device was used.
Bubble oxygen humidification had no effects on the 
need for intubation or noninvasive ventilation during 
ICU stay. The incidence of ear, nose or throat infection, 
the duration of ICU stay and ICU mortality were also 
similar in the HO and NHO groups. Detailed results are 
presented in AF (Table AF-2).
Discussion
This randomized non-inferiority study demonstrated 
that oxygen therapy-related discomfort was relatively low 
among oxygen-dependent ICU patients. Conversely to 
the set hypothesis, this study did not allow to conclude 
that delivering dry oxygen was non-inferior than deliv-
ering oxygen moistened with bubble humidifiers after 
Fig. 3 Absolute difference (with confidence interval) between the 15-item comfort scores at H24 after randomization between humidified oxygen 
(HO) and non-humidified (NHO) oxygen. NHO was non-inferior compared to HO in terms of comfort at H24
Table 2 Effects of humidification strategy according to oxygen flow rate (non-inferiority analyses) at H6–H8 and H24 (per 
protocol analysis)
HO humidified oxygen, NHO non-humidified oxygen, CI confidence interval
a For non-inferiority analysis
Oxygen flows Results presentation HO group comfort 
score
NHO group 
comfort 
score
Absolute difference 
between NHO group 
mean score and HO 
group mean score
[90% CI]
Relative difference 
between NHO group 
mean score and HO 
group mean score
[90% CI]
Interpretation
≤4 L/min
H6–H8
Mean ± SDa 26.1 ± 19.4
20% NI margin =+5.2
27.9 ± 22.2 + 1.8 [− 2.0; + 5.5] + 6.9 [− 7.7; + 21.1] Non-conclusive
Median [IQR] 21 [10.8; 37.5] 22 [11; 38.5]
>4 L/min
H6–H8
Mean ± SDa 29.3 ± 22.1
20% NI margin = + 5.9
33.9 ± 24.2 + 4.6 [− 1.6; + 10.8] + 15.7 [− 5.5; + 36.9] Non-conclusive
Median [IQR] 22.5 [17.8; 36.5] 25 [18.5; 45]
≤4 L/min
H24
Mean ± SDa 29.6 ± 19.7
20% NI margin = + 5.9
24.8 ± 21.0 − 4.8 [− 9.1; − 0.5] − 16.2 [− 30.7; − 1.7] Non-inferiority
Median [IQR] 25.5 [13.5; 42.8] 21 [12; 34]
>4 L/min
H24
Mean ± SDa 23.8 ± 16.6
20% NI margin = + 4.8
36.4 ± 19.5 + 12.6 [+ 4.9; + 20.4] + 52.9 [+ 20.6; + 85.7] Non-conclusive
Median [IQR] 21 [12; 34] 33 [18.5; 43.5]
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6–8 h of oxygen administration. At H24, NHO was non-
inferior to HO for the general patient. While NHO was 
demonstrated to be non-inferior to HO in the subgroup 
of patients receiving flows lower than or equal to 4  L/
min of oxygen, in patients receiving more than 4 L/min 
of oxygen, a post hoc superiority analysis showed higher 
discomfort when dry oxygen was administered compared 
to bubble-humidified oxygen.
Both at H6–H8 and at H24, less than 20% of the 
patients reported significant discomfort scores (above 
45/150). These score levels are much lower than previ-
ous data reported by Campbell et  al. [2] who noticed 
that almost 50% of patients receiving oxygen at flow rates 
above 5  L/min either with or without humidification 
complained of significant discomfort. The discomfort 
recorded in the present study was also lower compared to 
the data of Chanques et al. [3] who reported that 29% of 
the patients reported moderate-to-severe discomfort for 
oxygen flows of more than 5 L/min. Possible explanations 
of these differences could be the use of non-comparable 
scales to assess comfort or different thresholds chosen to 
conclude to significant discomfort.
According to the previously published data [2, 3, 5, 12], 
it was anticipated to record, in our population, a mean 
15-item discomfort score around 45/150 with a relatively 
low dispersion of the values. However, the mean com-
fort score values collected in our study were much lower 
than expected with very tight difference between the 
HO and NHO groups. In addition, the dispersion of the 
values was much broader than expected. Consequently, 
the power of our study turns out to be insufficient to con-
clude to non-inferiority of delivering dry oxygen. Consid-
ering the 15-item score values recorded in our study and 
a clinically significant threshold of 5.4 for the difference 
between comfort scores to conclude to non-inferiority, 
we found that one thousand four hundred and seventy-
eight patients (739 patients per arm) would have been 
needed to have a power of 80% in this non-inferiority 
trial (absolute difference between HO and NHO comfort 
scores at H6–H8 of 2.8 points, SD = 20.1, α risk = 0.05, 
unilateral tests). This number seems definitely too high 
to repeat the study to be able to answer to the question 
of potential non-inferiority of using bubble humidifiers to 
deliver oxygen to ICU patients.
Compared to previously published studies focused on 
patients’ discomfort during oxygen therapy [2, 3, 5, 7, 12, 
14–21], we used a 15-item specific comfort scale to assess 
all the components of oxygen therapy-related discomfort. 
We also evaluated comfort on a prolonged period of time.
In addition to the limited power of this study, some 
other limitations have to be mentioned. First, the discom-
fort scale used in the present study is new and not stand-
ardized. It was not validated in previous works. A scale 
validation was, however, performed in the same dataset 
but in other patient groups and is provided in AF. Sec-
ond, no formal delirium diagnosis was performed before 
the oxygen-related discomfort assessment. However, 
only patients who had a Glasgow Coma Scale at 15/15 
Fig. 4 Relative difference (with confidence interval) between non-humidified oxygen (NHO) group mean score and humidified oxygen (HO) group 
mean score at H6–H8 and H24
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could be included in the study. To standardize the oxy-
gen-related discomfort assessment, a health practitioner 
asked the patient to quote each of the fifteen items of the 
scale one by one. Third, as both comfortable and uncom-
fortable patients were included in the study, it could have 
been difficult to demonstrate a benefice potentially lim-
ited to the uncomfortable patients. Fourth, the subgroup 
analyses comprised a relatively small number of patients. 
Fifth, this study did not address the question of the 
impact of bubble humidification in tracheostomized or 
in pediatric patients. Finally, the conclusions of our study 
cannot be generalized for heated humidification, a tech-
nique with much higher potential to moisten delivered 
gas. Further studies are needed to explore the specific 
question of heated humidification on comfort at different 
gas flows.
Conclusions
This study failed to demonstrate the non-inferiority, in 
terms of comfort, of dry oxygen compared to bubble-
humidified oxygen in critically ill patients receiving 
oxygen after 6–8 h of oxygen therapy. No differences in 
clinical outcomes were found between dry oxygen and 
bubble-humidified oxygen. Subgroup analysis on data 
recorded after 24  h of oxygen therapy suggests that dry 
oxygen is non-inferior to bubble-humidified oxygen in 
patients receiving low (≤ 4  L/min) flow of oxygen but 
could be associated with a higher level of discomfort in 
patients receiving oxygen at higher (> 4 L/min) flows.
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